[ET Net News Agency, 23 October 2025] REMEGEN (09995) fell 10.1% to HK$82.7.
It hits an intra-day low of HK$82.2, hitting an 1-month low, and an intra-day high of HK$91.2. The total shares traded was 5.43 million, with a value of HK$466.81m. The active buy/sell ratio is 39:61, with net selling turnover of HK$96.6m. UBS accounts for greatest net responsive buying turnover of HK$11.41m, with volume weighted average price of HK$85.34. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$7.8m, with volume weighted average price of HK$86.042. The stock has fallen a combined 14.2% over the past 2 consecutive trading days.
Basic Information| Nominal | 82.700 | % Chg | -10.06% |
| High | 91.200 | Low | 82.200 |
| Shares Tr | 5.43m | Turnover | 466.81m |
| 10-D SMA | 91.725 | %H.V | 86.204 |
| 20-D SMA | 102.788 | VWAP | 86.009 |
| 50-D SMA | 97.655 | RSI14 | 36.077 |
Status: Hitting an 1-month low, active buy/sell ratio is 39:61, with net selling turnover of HK$96.6m, falling a combined 14.2% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| REMEGEN (09995) | 82.70 | -10.06 |
| SINO BIOPHARM (01177) | 6.92 | -3.89 |
| 3SBIO (01530) | 26.28 | -4.64 |
| EVEREST MED (01952) | 48.28 | -3.29 |
| WUXI XDC (02268) | 64.65 | -4.72 |
| ASCENTAGE-B (06855) | 64.65 | -4.36 |
| SKB BIO-B (06990) | 425.60 | -6.13 |
| DUALITYBIO-B (09606) | 305.00 | -3.05 |
| ZAI LAB (09688) | 21.80 | -4.55 |
| AKESO (09926) | 112.70 | -3.26 |
(ed)
